Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia

American Journal of Hematology

Volumn 84, Issue 6, 2009, Pages 328-334

  Flanagan, Jonathan M ^a   Steward, Shirley ^a   Hankins, Jane S ^a   Howard, Thad M ^a   Neale, Geoffrey ^a   Ware, Russell E ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3 CYCLOPENTYLOXY 4 METHOXYBENZYL) 6 ETHYLAMINO 8 ISOPROPYL 3H PURINE; ALBUMIN; AMINOPEPTIDASE; APOLIPOPROTEIN; APOLIPOPROTEIN L1; BETA2 GLYCOPROTEIN 1; C REACTIVE PROTEIN; CCL18 CHEMOKINE; CHEMOKINE; COMPLEMENT FACTOR H; CYCLIN D1; CYTOCHROME P450 1A2; DEFENSIN; DEFENSIN ALPHA; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 2B17; GLUTATHIONE TRANSFERASE M1; GLYCINE METHYLTRANSFERASE; HEME OXYGENASE 1; HEPATOCYTE NUCLEAR FACTOR 6; HEPCIDIN; INITIATION FACTOR 5A; IRON; KLOTHO PROTEIN; NEUROTENSIN; NICOTINAMIDE METHYLTRANSFERASE; PHOSPHOLIPASE A2 GROUP II; SERUM AMYLOID A; SULFATASE; SULFATASE 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; IRON OVERLOAD; LIVER BIOPSY; LIVER LEVEL; MALE; MEDICAL INFORMATION; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BETA-THALASSEMIA; CHILD; CHRONIC DISEASE; ERYTHROCYTE TRANSFUSION; FEMALE; GENE EXPRESSION; HUMANS; IRON; IRON OVERLOAD; LINEAR MODELS; LIVER; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 66849119384     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21407     Document Type: Article

References (55)

1. Miller ST, Wright E, Abboud M, et al. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr 2001;139:785-789. (Pubitemid 34014456)
2. Adams RJ, McKie VC, Brambilla D, et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials 1998;19:110-129. (Pubitemid 28085558)
3. Harmatz P, Butensky E, Quirolo K, et al. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood 2000;96:76-79. (Pubitemid 30456453)
4. Files B, Brambilla D, Kutlar A, et al. Longitudinal changes in ferritin during chronic transfusion: A report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP). J Pediatr Hematol Oncol 2002;24:284-290. (Pubitemid 34506616)
5. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999;341:1986-1995. (Pubitemid 30010408)
6. Cohen A. Treatment of transfusional iron overload. Am J Pediatr Hematol Oncol 1990;12:4-8. (Pubitemid 20132083)
7. Bottomley SS. Secondary iron overload disorders. Semin Hematol 1998;35: 77-86. (Pubitemid 28047044)
8. Kushner JP, Porter JP, Olivieri NF. Secondary iron overload. Hematol Am Soc Hematol Educ Program 2001;47-61.
9. Fung EB, Harmatz P, Milet M, et al. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload. Am J Hematol 2007;82:255-265. (Pubitemid 46564319)
10. Sohn YS, Breuer W, Munnich A, Cabantchik ZI. Redistribution of accumulated cell iron: A modality of chelation with therapeutic implications. Blood 2008;111:1690-1699. (Pubitemid 351213461)
11. Deugnier YM, Loreal O, Turlin B, et al. Liver pathology in genetic hemochromatosis: A review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992;102:2050-2059.
12. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699.
13. Dennis G, Sherman BT, Hosack DA, et al. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 2003;4:3.
14. Anderson GJ. Mechanisms of iron loading and toxicity. Am J Hematol 2007; 82(12 Suppl):1128-1131. (Pubitemid 350221242)
15. Chen YM, Shiu JY, Tzeng SJ, et al. Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma. Int J Cancer 1998;75:787-793. (Pubitemid 28145829)
16. Avila MA, Berasain C, Torres L, et al. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J Hepatol 2000;33:907-914.
17. Mudd SH, Cerone R, Schiaffino MC, et al. Glycine N-methyltransferase defi- ciency: A novel inborn error causing persistent isolated hypermethioninaemia. J Inherit Metab Dis 2001;24:448-464. (Pubitemid 32894514)
18. Augoustides-Savvopoulou P, Luka Z, Karyda S, et al. Glycine N-methyltransferase deficiency: A new patient with a novel mutation. J Inherit Metab Dis 2003;26:745-759. (Pubitemid 38139376)
19. Dimitriou E, Verhoek M, Altun S, et al. Elevated plasma chemokine CCL18/ PARC in b-thalassemia. Blood Cells Mol Dis 2005;35:328-331. (Pubitemid 41627797)
20. Brown KE, Mathahs MM, Broadhurst KA, Weydert J. Chronic iron overload stimulates hepatocyte proliferation and cyclin D1 expression in rodent liver. Trans Res 2006;148:55-62. (Pubitemid 44142352)
21. Troadec MB, Courselaud B, Detivaud L, et al. Iron overload promotes cyclin D1 expression and alters cell cycle in mouse hepatocytes. J Hepatol 2006;44: 391-399. (Pubitemid 43069222)
22. Messner DJ, Kowdley KV. Neoplastic transformation of rat liver epithelial cells is enhanced by non-transferrin-bound iron. BMC Gastroenterol 2008;8:2.
23. Mannervik B, Alin P, Guthenberg C, et al. Identification of three classes of cytosolic glutathione transferase common to several mammalian species: Correlation between structural data and enzymatic properties. Proc Natl Acad Sci USA 1985;82:7202-7206. (Pubitemid 16193710)
24. Seidegard J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988;85:7293-7297. (Pubitemid 18241871)
25. Board PG, Johnston PN, Ross VL, et al. Molecular genetics of the human glutathione S-transferase. Princess Takamatsu Symp 1990;21:199-211.
26. Nelson HH, Wiencke JK, Christiani DC, et al. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis 1995;16:1243-1246.
27. Wu KH, Chang JG, Ho YJ, et al. Glutathione S-transferase M1 gene polymorphisms are associated with cardiac iron deposition in patients with beta-thalassemia major. Hemoglobin 2006;30:251-256. (Pubitemid 43977327)
28. Park MH, Joe YA, Kang KR. Deoxyhypusine synthase activity is essential for cell viability in the yeast saccharomyces cerevisiae. J Biol Chem 1998;273: 1677-1683. (Pubitemid 28133696)
29. Tome ME, Gerner EW. Hypusine modification in eukaryotic initiation factor 5A in rodent cells selected for resistance to growth inhibition by ornithine decarboxylase-inhibiting drugs. Biochem J 1996;320(Part 1):55-60. (Pubitemid 26400160)
30. Rosorius O, Reichart B, Kratzer F, et al. Nuclear pore localization and nucleocytoplasmic transport of eIF-5A: Evidence for direct interaction with the export receptor CRM1. J Cell Sci 1999;112:2369-2380. (Pubitemid 29381027)
31. Lipowsky G, Bischoff FR, Schwarzmaier P, et al. Exportin 4: A mediator of a novel nuclear export pathway in higher eukaryotes. EMBO J 2000;19:4362-4371. (Pubitemid 30623747)
32. Hanauske-Abel HM, Slowinska B, Zagulska S, et al. Detection of a sub-set of polysomal mRNAs associated with modulation of hypusine formation at the G1-S boundary. Proposal of a role for eIF-5A in onset of DNA replication. FEBS Lett 1995;366:92-98.
33. Jao DL, Chen KY. Tandem affinity purification revealed the hypusine-dependent binding of eukaryotic initiation factor 5A to the translating 80S ribosomal complex. J Cell Biochem 2006;97:583-598. (Pubitemid 43265317)
34. Li AL, Li HY, Jin BF, et al. A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosis. J Biol Chem 2004;279:49251-49258. (Pubitemid 39625810)
35. Moore CC, Martin EN, Lee G, et al. Eukaryotic translation initiation factor 5A small interference RNA-liposome complexes reduce inflammation and increase survival in murine models of severe sepsis and acute lung injury. J Infect Dis 2008;198:1407-1414.
36. Kearney SL, Nemeth E, Neufeld EJ, et al. Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer 2007;48:57-63. (Pubitemid 44871594)
37. Origa R, Galanello R, Ganz T, et al. Liver iron concentrations and urinary hepcidin in {beta}-thalassemia. Haematologica 2007;92:583-588. (Pubitemid 350144260)
38. De Domenico I, Ward DM, Langelier C, et al. The molecular mechanism of Hepcidin-mediated ferroportin down-regulation. Mol Biol Cell 2007;18:2569-2578. (Pubitemid 47025722)
39. Kattamis A, Papassotiriou I, Palaiologou D, et al. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major. Haematologica 2006;91:809-812. (Pubitemid 44014549)
40. Sheftel AD, Kim SF, Ponka P. Non-heme induction of heme oxygenase-1 does not alter cellular iron metabolism. J Biol Chem 2007;282:10480-10486. (Pubitemid 47093404)
41. Mostert V, Nakayama A, Austin LM, et al. Serum iron increases with acute induction of hepatic heme oxygenase-1 in mice. Drug Metab Rev 2007;39: 619-626. (Pubitemid 47355724)
42. Kartikasari AE, Wagener FA, Yachie A, et al. Hepcidin suppression and defective iron recycling account for dysregulation of iron homeostasis in heme oxygenase-1 deficiency. J Cell Mol Med, in press.
43. Ferris CF, Armstrong MJ, George JK, et al. Alcohol and fatty acid stimulation of neurotensin release from rat small intestine. Endocrinology 1985;116: 1133-1138. (Pubitemid 15136974)
44. Assimakopoulos SF, Vagianos CE, Zervoudakis G, et al. Gut regulatory peptides bombesin and neurotensin reduce hepatic oxidative stress and histological alterations in bile duct ligated rats. Regul Pept 2004;120:185-193. (Pubitemid 38726207)
45. Drewe J, Mihailovic S, D'Amato M, Beglinger C. Regulation of fat-stimulated neurotensin secretion in healthy subjects. J Clin Endocrinol Metab 2008;93: 1964-1970.
46. Morimoto-Tomita M, Uchimura K, Werb Z, et al. Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J Biol Chem 2002;277:49175-49185. (Pubitemid 36014346)
47. Lai JP, Sandhu DS, Yu C, et al. Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma. Hepatology 2008;47:1211-1222.
48. Jenkins ZA, Hagar W, Bowlus CL, et al. Iron homeostasis during transfusional iron overload in beta-thalassemia and sickle cell disease: Changes in iron regulatory protein, hepcidin, and ferritin expression. Pediatr Hematol Oncol 2007;24:237-243. (Pubitemid 47026969)
49. Barisani D, Pelucchi S, Mariani R, et al. Hepcidin and iron-related gene expression in subjects with dysmetabolic hepatic iron overload. J Hepatol 2008;49:123-133.
50. Niederkofler V, Salie R, Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest 2005; 115:2180-2186. (Pubitemid 41134159)
51. Du X, She E, Gelbart T, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science 2008;320:1088-1092.
52. Finberg KE, Heeney MM, Campagna DR, et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 2008;40: 569-571.
53. Jain N, Thatte J, Braciale T, et al. Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays. Bioinformatics 2003;19:1945-1951. (Pubitemid 37322339)
54. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc 1995;B57:289-300.
55. Hosack DA, Dennis G, Sherman BT, et al. Identifying biological themes within lists of genes with EASE. Genome Biol 2003;4:R70.